Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.28
1.63%
After-hours: Aug 15, 2025, 07:36 PM EDT
Psyence Biomedical Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
Period Ending | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Cash & Equivalents | 1.93M | 733.19 | 88.17K | 9.8K | 15.96K | 128.68K | 214.94K | 306.88K | 431.9K | 648.28K | 9.91K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 12.52M | 16.54M | 16.12M | 257.73M | 255.92M | 255.12M | 255.01M | 255M | n/a |
Other Long-Term Assets | n/a | 0.00 | n/a | n/a | n/a | n/a | 16.23K | 94.41K | 171.74K | 248.65K | 208.06K |
Receivables | 125.08K | n/a | 53.66K | 67.18K | 60.9K | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 29.61K | 71.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 324.94K | n/a |
Total Current Assets | 2.24M | 1.13K | 162.52K | 181.39K | 288.6K | 1.21M | 540.93K | 652.54K | 797.2K | 973.22K | 9.91K |
Property-Plant & Equipment | 10.13K | 5.49 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 10.13K | 5.49 | 12.52M | 16.54M | 16.12M | 257.73M | 255.94M | 255.22M | 255.18M | 255.25M | 208.06K |
Total Assets | 2.25M | 1.13K | 12.68M | 16.73M | 16.4M | 258.93M | 256.48M | 255.87M | 255.98M | 256.22M | 217.98K |
Account Payables | 805.61K | 562.35 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.5M | 10.45K | 1.61M | 1.18M | 685K | n/a | n/a | n/a | n/a | n/a | 90.09K |
Other Current Liabilities | 190.11K | 968.70 | 14.57M | 14.09M | 14.19M | 14.27M | 187.04K | 213.7K | 142.67K | 68.7K | 182.38K |
Total Current Liabilities | 3.51M | 12.1K | 16.18M | 15.26M | 14.88M | 14.27M | 187.04K | 213.7K | 142.67K | 68.7K | 272.47K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 13.88M | 14.01M | 16.24M | 19.51M | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 13.88M | 14.01M | 16.24M | 19.51M | n/a |
Total Liabilities | 3.51M | 12.1K | 16.18M | 15.26M | 14.88M | 14.27M | 14.07M | 14.23M | 16.38M | 19.58M | 272.47K |
Total Debt | 2.5M | 10.45K | 1.61M | 1.18M | 685K | n/a | n/a | n/a | n/a | n/a | 90.09K |
Common Stock | 52.94M | 46.13K | 12.57M | 16.61M | 16.18M | 258.55M | 255.92M | 255M | 255M | 255M | 661.00 |
Retained Earnings | -54.5M | -57.46K | -16.07M | -15.15M | -14.65M | -13.9M | -13.51M | -13.36M | -15.4M | -18.36M | -79.49K |
Comprehensive Income | 260.02K | 361.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -1.26M | -10.97K | -3.5M | 1.46M | 1.52M | 244.66M | 242.41M | 241.64M | 239.6M | 236.65M | -54.49K |
Total Investments | n/a | n/a | 12.52M | 16.54M | 16.12M | 257.73M | 255.92M | 255.12M | 255.01M | 255M | n/a |